Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by mercedesmanon Aug 17, 2021 12:18pm
164 Views
Post# 33717190

RE:Worth listening to Scott Gottlieb....

RE:Worth listening to Scott Gottlieb....Excellent video FF.

Whether we like it or not (hint we do) there will be a growiing demand for some abilty to objectively measure antibodies in the general population, as time marches forward and vaccine effects begin to wear off.

For expediancey they will start with logical groups first (for boosters).  They include:
  • immunocompromised people
  • LT Care homes
  • perhaps health care workers

...then...

they need to figure out what other people in the general popultion will need boosters.

Even individuals who are not antivaxers will want to know that they really need a booster before getting one...IMO

Bring on personalized medicine and diagnostics to determine need and the best use of resources going forward.

MM
<< Previous
Bullboard Posts
Next >>